Startup Diligence
Diligence report Energy Technology / portable nuclear microreactors Private unicorn / growth-stage advanced nuclear hardware company

Radiant Nuclear

Radiant Nuclear Startup Diligence Report

Proceed only to deep technical, regulatory, financial, and contract diligence. A positive thesis requires proving that Kaleidos can be safely licensed, tested, manufactured at repeatable cost, fueled on schedule, insured, sited with public acceptance, and sold under contracts that cover nuclear-grade capex and lifecycle liabilities.

Company profile

Radiant Nuclear Startup Diligence Report

Radiant Nuclear is a credible public-source unicorn candidate in advanced nuclear hardware: public sources support the $1.8B valuation headline, more than $300M new funding, a 1 MWe Kaleidos microreactor product claim, DOME demonstration pathway, R-50 factory licensing milestone, and customer or strategic demand signals from Equinix, the Department of the Air Force, and Lockheed Martin Ventures. The diligence posture remains high-risk because the company is pre-commercial, nuclear-regulated, capital intensive, dependent on first-of-a-kind engineering and HALEU/TRISO supply, and lacks public audited financials or binding-contract economics.

Website
www.radiantnuclear.com
Sector
Energy Technology / portable nuclear microreactors
Geography
United States
Stage
Private unicorn / growth-stage advanced nuclear hardware company
Known aliases
Radiant, Radiant Industries, Radiant Industries, Inc., Kaleidos
Report version
1.0
Timezone
UTC

Executive summary

Strengths

  • Public news and market-list evidence support Radiant as a unicorn valued around $1.8B after a more than $300M round.
  • Company sources consistently describe Kaleidos as a compact 1 MWe portable microreactor with 1.9 MW thermal output and factory assembly.
  • Government and company sources support real regulatory engagement with DOE/DOME, NRC Part 70 review, and Air Force ANPI site-selection next steps.

Risks

  • Nuclear licensing and NEPA approvals are incomplete and could delay or prevent demonstration, factory operations, and customer deployments.
  • First-of-a-kind reactor, fuel, factory, and supply-chain execution risk is material despite public milestone progress.
  • No public financial statements, ARR, backlog economics, unit-cost evidence, or runway data are available.

Gaps

    Risk register

    high medium likelihood

    R-001: Licensing, NEPA, and regulatory approvals incomplete

    DOE final authorization/readiness review, NRC R-50 license completion, NEPA/site approvals, and commercial operating pathways remain open.

    Diligence request: Run specialist regulatory diligence on DOE, NRC, DAF/DIU, NEPA, state/local, and operating-license critical paths.

    high medium likelihood

    R-002: First-of-a-kind reactor and factory execution risk

    Kaleidos, DOME testing, R-50 production, and 2028 deployment require successful engineering, QA, manufacturing, safety, and operations execution.

    Diligence request: Review design reviews, test plans/results, QA program, manufacturing readiness, FMEA, and integrated master schedule.

    high medium likelihood

    R-004: Valuation and preference stack may diverge from public headline

    The $1.8B headline does not disclose liquidation preferences, anti-dilution, debt, warrants, option pool, or milestone tranching.

    Diligence request: Review financing documents, cap table, board approvals, option ledger, debt/warrants, and strategic side letters.

    high medium likelihood

    R-005: Product performance and lifecycle claims not independently proven

    Public claims about output, cooling, fuel, deployment speed, lifetime, and refueling require independent technical validation.

    Diligence request: Review test reports, safety analysis, O&M model, service manuals, reliability data, and customer acceptance tests.

    high medium likelihood

    R-006: Nuclear safety, environmental, insurance, and liability exposure

    Special nuclear material, site deployment, transport, waste, worker safety, public acceptance, and product liability create material legal exposure.

    Diligence request: Review insurance, indemnities, safety and emergency plans, environmental permits, NEPA record, and liability reserves.

    high medium likelihood

    R-008: HALEU, TRISO, and nuclear-grade supply chain dependencies

    Fuel, enrichment, graphite, pressure vessels, qualified suppliers, and export controls are critical dependencies.

    Diligence request: Review fuel/enrichment contracts, supplier quality, alternates, export controls, delivery commitments, and inventory buffers.

    high medium likelihood

    R-009: Export-control, hazardous-material, and supplier compliance burden

    Supplier terms reference ITAR/EAR and hazardous/restricted materials; compliance failures could disrupt programs or trigger liability.

    Diligence request: Review export classifications, supplier compliance program, training, audits, and restricted-material handling procedures.

    high unknown likelihood

    R-003: Financial quality, runway, and unit economics are opaque

    Public funding does not reveal burn, remaining cash, reactor cost, gross margin, capex, revenue recognition, or deployment profitability.

    Diligence request: Obtain audited financials, monthly management accounts, runway, capex budget, unit economics, and customer revenue model.

    Chapter 01

    01Financial Information

    Public evidence supports funding and valuation headlines, but audited financials, projections, cap table, debt, tax, accounting policies, unit economics, and customer backlog are not public.

    I.A Annual and quarterly financial information for the past three years

    not publicly verifiable confidence: low

    Public sources do not disclose income statements, balance sheets, cash flows, backlog, AR aging, revenue by product, gross margin, or unit economics.

    Evidence gaps

    • Audited financials, management accounts, cash runway, budget-to-actuals, backlog, AR aging, gross-margin bridge, and unit-cost model.

    Hidden risks

    • Cash burn, reactor capex, manufacturing yield, warranty, insurance, and nuclear-grade supplier costs could overwhelm headline funding.

    Follow-up questions

    • Provide FY2023-FY2026 monthly financials, board KPI packs, cash runway, backlog schedule, and reactor cost model by deployment scenario.
    Public financial and unit-economic signal ledger
    metricpublic signalstatusdiligence request
    Revenue / ARRNo public revenue or ARR statements found.not_publicly_verifiableAudited financials and customer revenue by product/site.
    BacklogEquinix 20-reactor deal with deposits is public, but contract value is not disclosed.partially_verifiedBacklog schedule, deposit accounting, refundability, and conversion gates.
    CapexR-50 factory and DOME test are public uses of capital.partially_verifiedFactory budget, committed spend, contingency, and burn forecast.

    I.B Financial Projections

    partially verified confidence: low

    Public projections are limited to milestone-oriented statements about DOME testing, R-50 factory scale, and 2028 deployments.

    Evidence gaps

    • Three-year financial model, capex budget, contingency reserve, pricing assumptions, working-capital plan, and external financing assumptions.

    Hidden risks

    • A delay in DOE, NRC, NEPA, HALEU, or factory milestones could shift revenue years while increasing burn.

    Follow-up questions

    • Provide integrated forecast showing reactor test gates, factory licensing, production ramp, customer conversion, capex draw, financing needs, and downside cases.
    Radiant funding and commercialization timeline Timeline of public funding, demonstration, factory, and deployment milestones.

    I.C Capital Structure

    partially verified confidence: medium

    Public sources identify headline financing and investors, not shares outstanding, ownership, preferences, notes, warrants, or debt.

    Evidence gaps

    • Cap table, financing documents, debt schedule, option plan, SAFE/note ledger, investor rights, board approvals, and 409A/valuation support.

    Hidden risks

    • Liquidation preferences, milestone tranched financing, debt, warrants, or government-contract obligations could materially change equity value.

    Follow-up questions

    • Reconcile the $1.8B headline to current fully diluted ownership, preferences, cash, debt, and remaining financing commitments.
    Capital structure and ownership snapshot
    stakeholderpublic positiondiligence caveat
    Draper AssociatesLead investor in more than $300M round.Confirm ownership, preferences, board rights, and funding mechanics.
    Boost VCCo-lead investor in more than $300M round.Confirm ownership, preferences, side letters, and governance rights.
    Lockheed Martin VenturesStrategic investor in oversubscribed financing round.Review strategic rights, information rights, commercial rights, and change-of-control terms.
    Employees / option holdersNo public option-plan detail.Review option pool, grants, vesting, exercises, and retention budget.
    Public valuation and funding anchors Simple bar chart of disclosed funding and valuation values.

    I.D Other financial information

    partially verified confidence: medium

    Financing history is publicly visible at a high level; tax, accounting policy, revenue recognition, grant accounting, and deposit treatment are not public.

    Evidence gaps

    • Revenue recognition memo, tax positions, grant accounting, deposit liabilities, deferred revenue, and financing-history ledger.

    Hidden risks

    • Customer deposits, government awards, and long-cycle reactor sales may have complex revenue-recognition and refundability terms.

    Follow-up questions

    • Provide accounting memos for customer deposits, government contracts, R&D capitalization, inventory, warranty reserves, and decommissioning/liability provisions.
    Public funding-round and valuation history
    dateeventamount or valuesource read
    2025-12-17New funding led by Draper Associates and Boost VCMore than $300MSupports financing momentum but not terms.
    2025-12-19Los Angeles Times valuation articleMore than $1.8B valuationIndependent/news public valuation anchor.
    2025-12Wikipedia current-unicorn row$1.8B listed valuationMarket-list pointer; rely on underlying citations.
    Chapter 02

    02Products

    Radiant publicly describes Kaleidos as a compact portable nuclear microreactor with electric and thermal output, factory fueling/testing, air cooling, TRISO fuel, and PPA or direct-sale commercial models; product performance and economics still require technical diligence.

    II.A Description of each product

    partially verified confidence: medium

    Kaleidos is publicly positioned for remote communities, hospitals, data centers, military installations, disaster response, remote industry, and critical infrastructure, with 1 MWe electric and 1.9 MW thermal output claims.

    Evidence gaps

    • Validated performance data, design basis, safety analysis, product cost, maintenance plan, service-level commitments, decommissioning plan, and customer acceptance criteria.

    Hidden risks

    • Product claims remain pre-commercial; cost, lifetime, fuel cycle, maintenance, site requirements, safety case, and uptime are unproven publicly.

    Follow-up questions

    • Provide design-control documents, test data, fuel-cycle plan, deployment SOPs, operating-cost model, and commercial warranty/service obligations.
    Kaleidos product and feature matrix
    featurepublic claimverification statusdiligence need
    Electrical outputKaleidos can operate at 1 MW electric.verified as public claimTest data, duty cycle, degradation, and uptime.
    Thermal outputCan provide 1.9 MW thermal for heating or desalination.verified as public claimThermal integration design and customer economics.
    Fuel and coolingTRISO fuel and zero on-site water use with air cooling.partially_verifiedFuel qualification, safety case, waste, and cooling performance.
    Commercial modelPPA or direct unit sales.verified as public claimPricing, margin, service, liability, and revenue-recognition terms.
    Product pricing and economics comparison
    itempublic evidencediligence view
    Radiant PPAPPA option disclosed; price not disclosed.Cannot assess gross margin or customer savings without contract terms.
    Radiant direct saleDirect unit sales disclosed; price not disclosed.Requires bill of materials, fuel, installation, service, warranty, insurance, and decommissioning cost model.
    Competitor microreactorWestinghouse eVinci publicly states 5 MWe / 15 MWth output but no price.Compare Radiant on size, transportability, price, licensing, and deployment timing.
    Kaleidos product dependency architecture Product architecture from public claims and key dependencies.
    Chapter 03

    03Customer Information

    Public customer and partner evidence is meaningful but early: Equinix, Department of the Air Force / Buckley SFB, DOE/INL, Urenco, and Lockheed Martin are visible signals, but revenue, concentration, deposits, renewals, severed relationships, and supplier commitments are not public.

    III.A Top customers by application

    partially verified confidence: medium

    Public sources identify Equinix and Buckley SFB/DAF as major demand signals, but do not disclose revenue contribution or deployment economics.

    Evidence gaps

    • Contract values, deposit amounts, refundability, revenue recognition, deployment sites, customer acceptance tests, and support obligations.

    Hidden risks

    • Deposits and site selections may not convert to recognized revenue if licensing, NEPA, siting, price, or performance gates fail.

    Follow-up questions

    • Obtain signed customer contracts and reference calls for Equinix, DAF/Buckley, and any additional backlog.
    Public customer and use-case evidence
    customer or segmentpublic evidencegap
    EquinixRadiant says Equinix signed a deal with deposits for 20 Kaleidos microreactors.Contract value, deposit amount, refundability, deployment sites, and acceptance criteria.
    Department of the Air Force / Buckley SFBDAF announced Radiant Industries for Buckley SFB under ANPI.Contracting vehicle, site approval, NEPA outcome, economics, and operating responsibilities.
    Remote communities / hospitals / data centers / military installationsCompany homepage lists target applications.Pipeline, conversion rate, willingness to pay, and site-specific approvals.
    Public customer and partner concentration signal Publicly visible demand and partnership anchors by disclosed reactor count.

    III.B Strategic relationships

    partially verified confidence: medium

    Public strategic relationships include DOE/INL demonstration pathway, Lockheed Martin Ventures investment, Urenco HALEU enrichment reference, and Air Force/DIU engagement.

    Evidence gaps

    • Partnership agreements, DOE/INL test agreements, Urenco enrichment terms, Lockheed investment rights, Air Force contracting path, and marketing commitments.

    Hidden risks

    • Strategic announcements may create execution obligations, exclusivity, export-control constraints, or milestone defaults not visible publicly.

    Follow-up questions

    • Review all strategic agreements for exclusivity, IP ownership, data rights, default remedies, and change-of-control consent rights.
    Strategic relationships and partnerships
    partnernaturediligence gap
    DOE / INL / NRIC DOMEDemonstration pathway and safety-document review.Test agreement, milestone obligations, open safety items, and readiness-review conditions.
    Department of the Air Force / DIUANPI site-selection pathway for Buckley SFB.NEPA, siting, contract economics, operating model, and indemnities.
    Lockheed Martin VenturesStrategic investor adding defense/aerospace credibility.Strategic rights, commercial rights, data/IP rights, and conflict constraints.
    UrencoCompany-reported HALEU enrichment deal.Volume, price, delivery, quality, and alternate-source rights.

    III.C Revenue by customer

    not publicly verifiable confidence: low

    No public revenue-by-customer data is available; all customer concentration and recognized revenue must be treated as unknown.

    Evidence gaps

    • Revenue by customer, signed backlog, renewal terms, churn, concentration, and credit risk.

    Hidden risks

    • Early backlog may be concentrated in one data-center customer and government pilots with long approval cycles.

    Follow-up questions

    • Provide customer-level ARR/bookings/backlog, recognized revenue, deposits, cancellations, and expected conversion dates.

    III.D Significant relationships severed within the last two years

    not publicly verifiable confidence: low

    No severed customer, partner, or supplier relationships were identified in the public sources reviewed.

    Evidence gaps

    • Terminated relationships, lost proposals, customer objections, supplier nonconformances, and default notices.

    Hidden risks

    • Quiet termination of site, fuel, supplier, or customer arrangements could materially affect the 2028 deployment narrative.

    Follow-up questions

    • Provide lost-pipeline and terminated-relationship schedules for customers, suppliers, partners, and regulators.

    III.E Top suppliers

    partially verified confidence: medium

    Public supplier signals emphasize HALEU, TRISO fuel, graphite, pressure-vessel, and enrichment dependencies, but supplier concentration and purchase commitments are private.

    Evidence gaps

    • Supplier contracts, quality agreements, inspection records, alternate-source qualification, price-escalation terms, and delivery schedules.

    Hidden risks

    • HALEU availability, qualified nuclear-grade materials, export controls, and single-source manufacturing items could bottleneck the factory ramp.

    Follow-up questions

    • Review top supplier spend, supply agreements, quality history, nonconformance reports, export-control classifications, and alternate-source plans.
    Supplier and fuel dependency matrix
    dependencypublic signalrisk
    HALEU fuelCompany says it signed a DOE HALEU contract for the INL test.Availability, schedule, price, quality, and alternative supply.
    HALEU enrichmentCompany says it signed a binding commercial contract with Urenco.Volume and delivery terms are not public.
    TRISO fuel and nuclear-grade materialsTRISO fuel, graphite, and pressure-vessel assembly are publicly referenced.Nuclear-grade qualification and manufacturing yield.
    Supplier complianceSupplier terms reference hazardous/restricted material notices and ITAR/EAR/export compliance.Export control and hazardous-material compliance failures could disrupt supply.
    Chapter 04

    04Competition

    Radiant competes in a crowded advanced nuclear and microreactor field against startups, public companies, and incumbents; public differentiation centers on portability, 1 MWe scale, factory production, DOME timing, and defense/data-center demand signals.

    IV.A Competitive landscape by market segment

    partially verified confidence: medium

    Public competitor pages show active alternatives including Oklo advanced fission plants, X-energy advanced reactors and TRISO fuel, and Westinghouse eVinci microreactors.

    Evidence gaps

    • Win/loss data, price comparisons, site-level economics, power purchase terms, licensing schedules, and independent customer references.

    Hidden risks

    • Competitors may secure fuel, sites, government support, NRC approvals, and early customers before Radiant reaches repeatable production.

    Follow-up questions

    • Request competitive win/loss by segment, priced quotes, customer alternatives, and technical comparison against Oklo, X-energy, Westinghouse eVinci, diesel, batteries, and grid interconnects.
    Competitor comparison matrix
    companypublic positioningoverlap
    Radiant1 MWe portable Kaleidos microreactor, factory assembled and targeted for 2026 test / 2028 deployments.Target company.
    OkloAdvanced fission power plants; public company page emphasizes clean, reliable, affordable energy and fuel recycling.Advanced nuclear power for resilient/clean power customers.
    X-energyAdvanced nuclear reactors and TRISO fuel for industrial and electricity demand.Advanced reactor and fuel technology competing for customers, talent, and fuel/supply chain.
    Westinghouse eVinci5 MWe / 15 MWth microreactor for decentralized remote applications.Microreactor / remote-power competitor with incumbent nuclear brand.
    Basis-of-competition scoring
    axisradiant public positiondiligence issue
    PortabilityFactory-built, transportable 1 MWe unit.Verify site-prep, transport, security, and installation requirements.
    Deployment timing2026 fueled test and 2028 initial deployments.Validate regulatory critical path and manufacturing readiness.
    Fuel and supply chainDOE HALEU and Urenco enrichment references.Confirm deliverable fuel volume, price, timing, and alternates.
    Brand and balance sheetStrong venture and strategic investor signals.Compare to incumbent nuclear vendors and public company competitors.
    Advanced nuclear competitive positioning map Positioning map across unit scale and portability.
    Chapter 05

    05Marketing, Sales, and Distribution

    Go-to-market is public-announcement-led and relationship-driven, with likely enterprise, government, defense, data-center, remote-industry, and critical-infrastructure motions; sales productivity and budgets are not public.

    V.A Strategy and implementation

    partially verified confidence: medium

    Radiant positions Kaleidos as resilient power for remote communities, hospitals, data centers, military installations, defense, disaster response, remote industry, and critical infrastructure.

    Evidence gaps

    • Sales pipeline, qualification criteria, marketing spend, sales cycle length, proposal-to-contract conversion, pricing, and partner-channel economics.

    Hidden risks

    • Site-level permitting, community acceptance, nuclear insurance, long sales cycles, and procurement complexity may make broad marketing claims difficult to convert.

    Follow-up questions

    • Provide CRM pipeline, sales-cycle data, marketing budget, channel plan, PPA economics, and customer objections by segment.
    Distribution channels and GTM motions
    channelpublic evidencegap
    Direct enterprise / data centerEquinix 20-reactor deal with deposits.Contract value, procurement path, delivery gates, and customer financing.
    Government / defenseDAF/DIU selected Radiant for Buckley SFB under ANPI.Contract vehicle, NEPA, siting, security, operations, and indemnity terms.
    PPAHomepage says customers can purchase through PPAs.Energy price, term, financing, tax, insurance, and lifecycle obligations.
    Direct unit salesHomepage says direct unit sales are available.Unit price, margin, warranty, service, liability, and fuel obligations.
    Public marketing-signal summary
    signalevidencediligence read
    Funding pressMore than $300M round and investor quotes.Strengthens credibility but not customer economics.
    Government selectionDAF/DIU public ANPI pairing with Buckley SFB.High-value validation with substantial regulatory/site contingencies.
    Strategic investorLockheed Martin Ventures investment.Defense-market credibility; review strategic rights.
    GTM channel mix by public signal count Public channel evidence grouped by route to market.

    V.B Major Customers

    partially verified confidence: medium

    Equinix, DAF/Buckley, and strategic defense interest are visible, but customer pipeline value, conversion probability, and delivery milestones are private.

    Evidence gaps

    • Pipeline by stage, bookings, customer success plan, renewal model, support SLAs, and deployment acceptance criteria.

    Hidden risks

    • A small number of marquee relationships could dominate pipeline optics while remaining contingent on licenses, NEPA, site work, and financing.

    Follow-up questions

    • Validate pipeline with customer calls, signed orders, deposits, delivery dates, and termination/conversion gates.

    V.C Principal avenues for generating new business

    partially verified confidence: low

    Public avenues appear to be direct enterprise sales, government/defense programs, strategic partnerships, and credibility from public reactor/factory milestones.

    Evidence gaps

    • Channel strategy, reseller/system-integrator agreements, government-contract vehicles, and geographic expansion plan.

    Hidden risks

    • Direct sales may require specialized regulatory, safety, siting, fuel, and financing expertise that limits velocity.

    Follow-up questions

    • Provide channel map, demand-generation plan, government-contracting strategy, and commercial partner agreements.

    V.D Sales force productivity model

    not publicly verifiable confidence: low

    No public data was found for sales compensation, quotas, sales-cycle length, or sales-hiring plan.

    Evidence gaps

    • Sales roster, quota plan, commission plan, pipeline conversion, ASP, CAC, and deployment services capacity.

    Hidden risks

    • Nuclear sales cycles may be multi-year and dependent on customer financing, permits, and utility/regulator coordination.

    Follow-up questions

    • Provide sales capacity plan, quotas, compensation, stage conversion, customer acquisition cost, and bookings forecast.

    V.E Ability to implement marketing plan with current and projected budgets

    not publicly verifiable confidence: low

    Public funding is substantial, but there is no public budget tying capital to marketing, sales, site development, factory construction, and regulatory work.

    Evidence gaps

    • GTM budget, hiring plan, deployment budget, site-development spend, and sales/marketing ROI.

    Hidden risks

    • Underfunded commercial, deployment, or regulatory teams could delay conversion even if product milestones are achieved.

    Follow-up questions

    • Reconcile current cash and financing commitments to the full GTM and deployment plan through first commercial revenue.
    Chapter 06

    06Research and Development

    R&D evidence is stronger than commercial evidence: Radiant publicly reports DOE/DOME progress, reactor assembly, safety-document milestones, R-50 manufacturing plans, and senior technical hires; independent technical validation and full lifecycle costs remain private.

    VI.A Description of R&D organization

    partially verified confidence: medium

    Public leadership evidence includes a Chief Nuclear Officer hire and VP/Director hires across engineering, manufacturing, and supply chain, but org depth and retention are private.

    Evidence gaps

    • Engineering org chart, QA program staffing, employee retention, critical-role gaps, outsourced design dependencies, and consultant reliance.

    Hidden risks

    • A first-of-a-kind reactor program requires deep nuclear quality assurance, licensing, manufacturing, fuel, security, operations, and customer deployment teams.

    Follow-up questions

    • Review R&D org chart, quality program, design authority, retention, open roles, consultant statements of work, and safety-culture materials.
    Key R&D personnel and leadership
    person or grouprolesource read
    Doug BernauerCEO and FounderFounder-led reactor program; assess key-person dependency.
    Dr. Rita BaranwalChief Nuclear Officer; former Assistant Secretary for Nuclear Energy per company announcement.Strong nuclear credibility; verify employment, authority, and regulatory responsibilities.
    Dr. Mike StarrettChief Revenue Officer per company announcement.Commercial leadership relevant to first deployments.
    VP/Director hiresEngineering, manufacturing, and supply-chain leadership.Public hiring signal; full org depth remains private.
    R&D and regulatory milestone roadmap Roadmap from public R&D and regulatory milestones.

    VI.B New Product Pipeline

    partially verified confidence: medium

    The public pipeline centers on the Kaleidos Demonstration Unit, DOE/DOME startup pathway, R-50 production facility, and initial deployments beginning in 2028.

    Evidence gaps

    • Test results, integrated master schedule, critical path, technology readiness assessment, supplier qualification, manufacturing process validation, and failure-mode analyses.

    Hidden risks

    • Technical rework after DOME testing, NRC review questions, HALEU delays, or R-50 manufacturing issues could reset the pipeline.

    Follow-up questions

    • Obtain safety analyses, verification-and-validation evidence, design FMEA, manufacturing readiness level, quality records, and schedule-risk register.
    Public product and research pipeline
    projectpublic statusrisk
    Kaleidos Demonstration Unit at DOMEPlanned 2026 fueled test; DOE PDSA-intent approval complete but final safety/readiness review pending.Final authorization and performance risk.
    R-50 Production FacilityNRC accepted Part 70 application for detailed technical review.License, construction, QA, and manufacturing-scale risk.
    Initial customer deploymentsCompany says deployments begin in 2028.Dependent on test, licensing, fuel, factory, customer site, and financing milestones.
    Fuel and materialsDOE HALEU, Urenco enrichment, pressure vessel, and graphite publicly referenced.Qualified supply schedule and nuclear-grade quality.
    Chapter 07

    07Management and Personnel

    Public leadership evidence supports a founder-led company with notable senior hires, but complete organization structure, headcount, compensation, incentive plans, employee relations, and turnover are not public.

    VII.A Organization Chart

    partially verified confidence: medium

    A complete public org chart was not available; announcements identify founder/CEO, Chief Nuclear Officer, Chief Revenue Officer, COO, and broad VP/Director hiring.

    Evidence gaps

    • Full org chart, reporting lines, key-person succession, open requisitions, retention metrics, and outsourced critical roles.

    Hidden risks

    • Key-person risk and depth gaps in nuclear licensing, manufacturing quality, security, operations, and government contracting could slow execution.

    Follow-up questions

    • Provide current and projected org charts through first deployment, including safety, licensing, manufacturing, security, fuel, and field operations roles.
    Senior management roster
    namerolediligence note
    Doug BernauerCEO and FounderReview founder vesting, employment, IP assignment, and succession.
    Dr. Rita BaranwalChief Nuclear OfficerValidate authority over nuclear safety and regulatory program.
    Dr. Mike StarrettChief Revenue OfficerValidate pipeline ownership and sales/deployment capacity.
    Tori ShivanandanChief Operating OfficerValidate operating remit, manufacturing readiness, and deployment execution.
    Public senior leadership map Publicly visible senior leadership nodes.

    VII.B Historical and projected headcount by function and location

    partially verified confidence: low

    Public sources mention almost a dozen VP/Director hires across engineering, manufacturing, and supply chain but do not provide headcount history or forecasts.

    Evidence gaps

    • HRIS export, hiring plan, attrition, security-clearance needs, quality-assurance staffing, and training records.

    Hidden risks

    • Scaling from prototype/demo to licensed manufacturing may require a large nuclear-quality workforce not yet evidenced publicly.

    Follow-up questions

    • Provide monthly headcount by function/location, open roles, attrition, compensation bands, and critical-skill coverage.
    Headcount and hiring signals
    functionpublic signalfollow up
    EngineeringAlmost a dozen VP/Director hires across engineering, manufacturing, and supply chain.Headcount, attrition, critical roles, and schedule coverage.
    ManufacturingR-50 factory ramp is a central public milestone.Manufacturing org, quality program, training, and shift plan.
    Supply chainPublic references to HALEU, Urenco, graphite, and pressure-vessel inputs.Supplier management, quality, procurement staffing, and alternate-source plan.
    Sales / deploymentChief Revenue Officer role and customer announcements.Sales capacity, deployment project management, service, and customer-success staffing.
    Public headcount signal chart Publicly visible leadership/hiring signal by function.

    VII.C Senior management biographies

    partially verified confidence: medium

    Public announcements name Doug Bernauer, Rita Baranwal, Mike Starrett, and Tori Shivanandan in senior roles; deeper biographies and employment agreements were not reviewed.

    Evidence gaps

    • Employment agreements, board minutes approving officer roles, references, background checks, and succession plans.

    Hidden risks

    • Public bios do not prove performance management, succession depth, incentive alignment, or security/ethics history.

    Follow-up questions

    • Conduct management references and review employment, severance, IP assignment, noncompete/nonsolicit, and change-of-control terms.

    VII.D Compensation arrangements

    not publicly verifiable confidence: low

    Public sources do not disclose compensation, severance, benefits, retention bonuses, or special founder arrangements.

    Evidence gaps

    • Employment agreements, executive compensation, bonus plans, benefits, retention packages, and severance obligations.

    Hidden risks

    • Misaligned retention or incentive packages could drive turnover in critical technical and regulatory roles.

    Follow-up questions

    • Provide executive and critical-role compensation agreements, retention plan, benefits plan, and severance/change-of-control schedule.

    VII.E Incentive stock plans

    not publicly verifiable confidence: low

    No public incentive stock plan details were identified.

    Evidence gaps

    • Stock plan, option ledger, vesting schedule, board approvals, refresh policy, and 409A support.

    Hidden risks

    • Option pool size or repricing needs may dilute investors or impair hiring.

    Follow-up questions

    • Provide current option plan, grant ledger, reserved shares, exercises, cancellations, and planned refresh budget.

    VII.F Significant employee relations problems, past or present

    not publicly verifiable confidence: low

    No public employee-relations problems were identified in reviewed sources, but the search was not a substitute for HR/legal diligence.

    Evidence gaps

    • HR complaints, investigations, whistleblower logs, safety-culture assessments, OSHA records, and settlement agreements.

    Hidden risks

    • Nuclear safety culture, whistleblower processes, and workplace-safety matters are critical and not publicly assessable.

    Follow-up questions

    • Review employee-relations logs, safety-culture audits, code-of-conduct investigations, and any employment litigation or settlements.

    VII.G Personnel Turnover

    not publicly verifiable confidence: low

    No public turnover data was identified.

    Evidence gaps

    • Monthly attrition by function, exit-interview themes, open critical roles, employee-engagement results, and retention grants.

    Hidden risks

    • Loss of a small number of licensing, reactor-design, fuel, or manufacturing leaders could disrupt schedule-critical work.

    Follow-up questions

    • Provide turnover and retention analysis for 2024-2026, including critical technical, licensing, and manufacturing roles.
    Chapter 08

    08Legal and Related Matters

    Radiant is legally and regulatorily exposed by nuclear demonstration, special nuclear material handling, factory licensing, NEPA/site approvals, export controls, supplier compliance, insurance, product liability, IP, and material contract risks; public evidence shows progress but not final clearances.

    VIII.A Pending lawsuits against the Company

    not publicly verifiable confidence: low

    No pending lawsuits against Radiant were identified in the public web sources reviewed, but no comprehensive docket search or counsel confirmation was available.

    Evidence gaps

    • Counsel letter, docket searches, litigation schedules, threatened claims, indemnities, settlement agreements, and reserve analysis.

    Hidden risks

    • Product-liability, employment, supplier, IP, environmental, or regulatory matters may exist outside public sources reviewed.

    Follow-up questions

    • Have counsel run federal/state docket searches and provide a litigation/threatened-claims schedule with reserves and insurance coverage.
    Public litigation status ledger
    areapublic resultfollow up
    Claims against RadiantNo claims identified in reviewed public sources.Counsel docket search and litigation schedule.
    Claims initiated by RadiantNo claims identified in reviewed public sources.Counsel docket search and IP/enforcement schedule.
    Threatened claims / investigationsNot publicly verifiable.Counsel letter, board minutes, reserves, and settlement agreements.

    VIII.B Pending lawsuits initiated by Company

    not publicly verifiable confidence: low

    No pending lawsuits initiated by Radiant were identified in the public web sources reviewed.

    Evidence gaps

    • Active claims, demand letters, arbitration matters, settlement agreements, and IP enforcement records.

    Hidden risks

    • Quiet IP, supplier, or employee-restriction disputes could affect operations or defensibility.

    Follow-up questions

    • Provide complete schedule of claims initiated or threatened by Radiant and counsel assessment.

    VIII.C Environmental and employee safety issues and liabilities

    partially verified confidence: medium

    Public sources describe nuclear safety milestones, special nuclear material manufacturing review, and NEPA/site analysis next steps, but environmental, safety, OSHA, radiation-protection, and emergency-plan records are not public.

    Evidence gaps

    • NEPA documents, environmental permits, safety plan, radiation-protection program, OSHA history, emergency response plan, and decommissioning/waste plan.

    Hidden risks

    • Environmental review, emergency planning, radiation protection, waste handling, community opposition, and worker-safety requirements could materially alter timeline and cost.

    Follow-up questions

    • Review NEPA schedules, environmental permits, safety manuals, emergency plans, worker training, and radioactive-material handling procedures.
    Regulatory and agency action matrix
    agency or programpublic actionopen gate
    DOE / INL / DOMEDOE approved Radiant's DARK/PDSA-intent submission, second of three safety submittals.Final documented safety analysis, readiness review, authorization, startup, and test performance.
    NRC Part 70 / R-50NRC accepted R-50 Production Facility application for detailed technical review.Safety, environmental, technical evaluations, license issuance, construction, and operations.
    DAF / DIU ANPIRadiant paired with Buckley SFB; next steps include siting and NEPA analyses.NEPA, site approval, contract, community engagement, security, and operating model.
    NRC advanced reactors contextNRC public pages list advanced/new-reactor licensing resources.Radiant's full commercial operating pathway still requires counsel/regulatory review.
    Legal and regulatory timeline Public legal and regulatory milestones.

    VIII.D Material patents, copyrights, licenses, and trademarks

    not publicly verifiable confidence: low

    No formal patent/trademark docket was collected in this public-source pass; material IP ownership and freedom-to-operate remain open.

    Evidence gaps

    • Patent/trademark schedules, invention assignments, license agreements, government data-rights clauses, open-source use, and freedom-to-operate analysis.

    Hidden risks

    • Government-funded work, supplier designs, employee inventions, and strategic partners may create IP/data-rights encumbrances.

    Follow-up questions

    • Obtain IP schedule, prosecution files, license agreements, invention assignments, FTO opinion, and government-data-rights matrix.
    IP, contracts, insurance, and compliance gap table
    areapublic signaldiligence request
    IP / technologyProduct and manufacturing claims imply critical proprietary reactor know-how.Patent/trademark schedule, licenses, invention assignments, FTO, and government data-rights matrix.
    Customer contractsEquinix deal with deposits and DAF/ANPI selection are public.Executed contracts, deposits, termination, indemnity, site, and revenue-recognition terms.
    Supplier contractsHALEU, enrichment, graphite, and pressure-vessel dependencies are public.Supply, quality, price, schedule, export-control, and alternate-source documentation.
    InsuranceNo public coverage data.Nuclear liability, D&O, cyber, product, environmental, transportation, and workers-comp policies.

    VIII.E Insurance coverage and material exposures

    not publicly verifiable confidence: low

    Insurance coverage for nuclear demonstration, transportation, product liability, environmental liability, cyber, D&O, and workers compensation is not public.

    Evidence gaps

    • Insurance policies, nuclear liability coverage, government indemnities, exclusions, claims history, broker letters, and reserve analysis.

    Hidden risks

    • Nuclear liability, transportation, site, environmental, and product-warranty exclusions could leave material uninsured exposure.

    Follow-up questions

    • Review all insurance policies, indemnity frameworks, claims history, site-specific requirements, and gaps versus maximum probable loss.
    Risk heatmap Heatmap of major diligence risks.

    VIII.F Material contracts

    partially verified confidence: medium

    Publicly material contract categories include customer deposits, DOE/INL testing, HALEU and enrichment, supplier purchase orders, site/deployment agreements, and strategic investment rights; actual contracts are private.

    Evidence gaps

    • Customer contracts, supplier agreements, DOE/INL agreements, fuel/enrichment contracts, leases, construction contracts, and strategic-investor side letters.

    Hidden risks

    • Termination, refundability, indemnity, IP ownership, export-control, price-escalation, force-majeure, and change-of-control provisions could materially affect value.

    Follow-up questions

    • Build a material-contract matrix and review economics, obligations, IP/data rights, termination, indemnity, assignment, and regulatory conditions.

    VIII.G Regulatory agency problems

    partially verified confidence: high

    Public evidence shows regulatory progress, not problems, but major approvals remain pending across DOE, NRC, NEPA/site, and potentially operating-license pathways.

    Evidence gaps

    • Full regulatory docket, requests for additional information, agency meeting minutes, open commitments, NEPA schedule, and counsel/regulatory consultant assessment.

    Hidden risks

    • Requests for additional information, environmental opposition, rule changes, safety-review findings, or special nuclear material limits could delay or block milestones.

    Follow-up questions

    • Counsel should review DOE, NRC, DAF/DIU, state, local, and environmental filings with a milestone-critical-path analysis.

    Evidence

    Evidence claims
    IDClaimStatusSources
    EC-001 Public sources list Radiant as a unicorn valued at more than $1.8B after a more than $300M round. verified high SRC-001SRC-002
    EC-002 Radiant was founded in 2020 and is building mass-produced nuclear generators. verified medium SRC-004
    EC-003 Kaleidos is publicly described as a portable 1 MWe microreactor with 1.9 MW thermal output, air cooling, TRISO fuel, and factory assembly. partially verified medium SRC-003
    EC-004 Radiant announced more than $300M in new funding led by Draper Associates and Boost VC to support commercialization, R-50, and DOME. partially verified medium SRC-004SRC-002
    EC-005 NRC accepted Radiant's 10 CFR Part 70 application for R-50 Production Facility detailed technical review. partially verified high SRC-008SRC-014
    EC-006 DOE approved Radiant's DARK submission intended to meet PDSA requirements, but a final safety analysis and readiness review remained ahead. partially verified high SRC-005
    EC-007 The Department of the Air Force publicly paired Radiant with Buckley SFB under ANPI and identified siting and NEPA analyses as next steps. verified high SRC-006SRC-007
    EC-008 Radiant says it signed a deal with deposits for 20 Kaleidos microreactors with Equinix. partially verified medium SRC-004
    EC-009 Radiant publicly references DOE HALEU fuel and a binding commercial HALEU enrichment deal with Urenco. partially verified medium SRC-004
    EC-010 Radiant announced senior hires including a Chief Nuclear Officer, Chief Revenue Officer, and VP/Director hires across engineering, manufacturing, and supply chain. partially verified medium SRC-004
    EC-011 Lockheed Martin Ventures made a strategic investment in Radiant's oversubscribed financing round. partially verified medium SRC-009
    EC-012 Radiant's supplier terms publicly reference compliance obligations including ITAR/EAR/export controls and hazardous/restricted material notices. verified medium SRC-010
    EC-013 Public competitor sources show active advanced nuclear alternatives from Oklo, X-energy, and Westinghouse eVinci. verified medium SRC-011SRC-012SRC-013
    EC-014 Public sources reviewed do not disclose audited financial statements, ARR, gross margin, cash runway, headcount history, sales productivity, or cap-table terms. not publicly verifiable high SRC-002SRC-003SRC-004
    EC-015 No public litigation or formal IP docket was verified in this pass; legal matters require counsel review. not publicly verifiable low SRC-003SRC-010
    EC-016 Radiant publicly targets a 2026 reactor test and initial customer deployments beginning in 2028. partially verified medium SRC-004SRC-006
    EC-017 Radiant publicly references factory assembly, pressure-vessel delivery, and nuclear-grade graphite as part of first reactor assembly. partially verified medium SRC-004
    EC-018 NRC and agency sources frame advanced-reactor licensing and special nuclear material review as safety, environmental, and technical processes. partially verified medium SRC-008SRC-014
    EC-019 Radiant's public R-50 target is to scale toward 50 reactors per year within a few years of deployments beginning in 2028. partially verified medium SRC-002SRC-004
    EC-020 Radiant publicly targets use cases including remote villages, hospitals, data centers, military installations, disaster response, remote industry, and critical infrastructure. verified medium SRC-003SRC-004

    Disclaimer

    This report is a public-evidence diligence snapshot, not investment advice. Important financial, legal, technical, and contractual facts remain non-public and should be verified directly with management and primary documents before any investment decision.